Medium-term Venous Access in Congenital Heart Surgery

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This study is designed to evaluate medium-term central venous catheter placement in infants undergoing complex cardiac surgery using a new technique. This technique involves placement of the catheter into the inferior vena cava through a subcutaneous tunnel and through a tunnel between pericardium and diaphragm.

See also
Status	Clinical Trial	Phase
Terminated	`NCT00620945` - Use of Phenoxybenzamine [PBZ] IV to Assist High Flow Low Pressure Perfusion [HFLPP] on Cardio-pulmonary Bypass	N/A
Terminated	`NCT00215072` - Death Following Congenital Heart Surgery	N/A
Not yet recruiting	`NCT04234906` - Prevention of Post-Operative Cardiac Arrhythmias	Phase 4
Not yet recruiting	`NCT04945694` - Pain Management of Pecto-intercostal Fascial Block Versus Intravenous Fentanyl After Pediatric Cardiac Surgery	N/A

NCT number	NCT00852488
Study type	Interventional
Source	Vanderbilt University Medical Center
Contact
Status	Completed
Phase	N/A
Start date	March 2009
Completion date	January 2010

Medium-term Venous Access in Congenital Heart Surgery

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms